Jean Francois Formela - Jun 11, 2024 Form 4 Insider Report for Korro Bio, Inc. (KRRO)

Role
Director
Signature
/s/ Shelby Walker, attorney-in-fact
Stock symbol
KRRO
Transactions as of
Jun 11, 2024
Transactions value $
$0
Form type
4
Date filed
6/12/2024, 05:25 PM
Previous filing
Jun 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRRO Stock Option (Right to Buy) Award $0 +5.19K $0.00 5.19K Jun 11, 2024 Common Stock 5.19K $42.19 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.
F2 The Reporting Person is a member of Atlas XI and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any.